Development of hybrid baculovirus vectors for artificial MicroRNA delivery and prolonged gene suppression

Biotechnology and Bioengineering

Volumn 108, Issue 12, 2011, Pages 2958-2967

  Chen, Chiu Ling ^a   Luo, Wen Yi ^a   Lo, Wen Hsin ^a   Lin, Kun Ju ^b,c   Sung, Li Yu ^a   Shih, Yung Shen ^a   Chang, Yu Han ^b,d   Hu, Yu Chen ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

^d CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Baculovirus; MiRNA; RNA interference; Sleeping Beauty; Sustained expression

Indexed keywords

BACULOVIRUS; MIRNA; RNA INTERFERENCE; SLEEPING BEAUTY; SUSTAINED EXPRESSION;

CELL DEATH; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; RNA; VECTORS;

GENE EXPRESSION REGULATION;

BACULOVIRUS VECTOR; ENHANCED GREEN FLUORESCENT PROTEIN; MICRORNA;

APOPTOSIS; ARTHRITIS; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOMEGALOVIRUS; GENE CONSTRUCT; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE REPRESSION; GENE SEQUENCE; GENE TARGETING; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; HYBRID GENE; NONHUMAN; PROMOTER REGION; RNA INTERFERENCE; SEQUENCE ANALYSIS; SLEEPING BEAUTY GENE; SYNOVIOCYTE; TRANSPOSON; VIRAL GENE DELIVERY SYSTEM;

BACULOVIRIDAE; BIOLOGICAL AGENTS; CELL LINE; DNA TRANSPOSABLE ELEMENTS; DRUG CARRIERS; GENE EXPRESSION REGULATION; GENES, REPORTER; GENETIC VECTORS; GENOMIC INSTABILITY; GREEN FLUORESCENT PROTEINS; HUMANS; MICRORNAS; MUTAGENESIS, INSERTIONAL; RECOMBINATION, GENETIC; TRANSDUCTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

CYTOMEGALOVIRUS;

EID: 80054041983     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.23250     Document Type: Article

References (53)

1. Aagaard LA, Zhang J, von Eije KJ, Li H, Saetrom P, Amarzguioui M, Rossi JJ. 2008. Engineering and optimization of the miR-106b cluster for ectopic expression of multiplexed anti-HIV RNAs. Gene Ther 15: 1536-1549.
2. Abe T, Kaname Y, Wen X, Tani H, Moriishi K, Uematsu S, Takeuchi O, Ishii KJ, Kawai T, Akira S, Matsuura Y. 2009. Baculovirus induces type I interferon production through toll-like receptor-dependent and -independent pathways in a cell-type-specific manner. J Virol 83: 7629-7640.
3. Abe T, Matsuura Y. 2010. Host innate immune responses induced by baculovirus in mammals. Curr Gene Ther 10: 226-231.
4. Amendola M, Passerini L, Pucci F, Gentner B, Bacchetta R, Naldini L. 2009. Regulated and multiple miRNA and siRNA delivery Into primary cells by a lentiviral platform. Mol Ther 17: 1039-1052.
5. Bartel DP. 2009. MicroRNAs: Target recognition and regulatory functions. Cell 136: 215-233.
6. Boudreau RL, Martins I, Davidson BL. 2008. Artificial microRNAs as siRNA shuttles: Improved safety as compared to shRNAs in vitro and in vivo. Mol Ther 17: 169-175.
7. Brown BD, Naldini L. 2009. Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications. Nat Rev Genet 10: 578-585.
8. Chen C-Y, Lin C-Y, Chen G-Y, Hu Y-C. 2011a. Baculovirus as a gene delivery vector: Recent understandings of molecular alterations in transduced cells and latest applications. Biotechnol Adv Epub ahead of print. DOI: 10.1016/j.biotechadv.2011.04.004.
9. Chen H-C, Sung L-Y, Lo W-H, Chuang C-K, Wang Y-H, Lin J-L, Hu Y-C. 2008. Combination of baculovirus-mediated BMP-2 expression and rotating-shaft bioreactor culture synergistically enhances cartilage formation. Gene Ther 15: 309-317.
10. Chen C-Y, Wu H-H, Chen C-P, Chern S-R, Hwang S-M, Huang S-F, Lo W-H, Chen G-Y, Hu Y-C. 2011b. Biosafety assessment of human mesenchymal stem cells engineered by hybrid baculovirus vectors. Mol Pharmaceut Epub online. DOI: 10.1021/mp100368d.
11. Cheshenko N, Krougliak N, Eisensmith RC, Krougliak VA. 2001. A novel system for the production of fully deleted adenovirus vectors that does not require helper adenovirus. Gene Ther 8: 846-854.
12. Chuang C-K, Sung L-Y, Hwang S-M, Lo W-H, Chen H-C, Hu Y-C. 2007. Baculovirus as a new gene delivery vector for stem cells engineering and bone tissue engineering. Gene Ther 14: 1417-1424.
13. Chung KH, Hart CC, Al-Bassam S, Avery A, Taylor J, Patel PD, Vojtek AB, Turner DL. 2006. Polycistronic RNA polymerase II expression vectors for RNA interference based on BIC/miR-155. Nucleic Acids Res 34: e53.
14. Ciceri F, Bonini C, Stanghellini MTL, Bondanza A, Traversari C, Salomoni M, Turchetto L, Colombi S, Bernardi M, Peccatori J, Pescarollo A, Servida P, Magnani Z, Perna SK, Valtolina V, Crippa F, Callegaro L, Spoldi E, Crocchiolo R, Fleischhauer K, Ponzoni M, Vago L, Rossini S, Santoro A, Todisco E, Apperley J, Olavarria E, Slavin S, Weissinger EM, Ganser A, Stadler M, Yannaki E, Fassas A, Anagnostopoulos A, Bregni M, Stampino CG, Bruzzi P, Bordignon C. 2009. Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): A non-randomised phase I-II study. Lancet Oncol 10: 489-500.
15. Cullen BR. 2009. Viral and cellular messenger RNA targets of viral microRNAs. Nature 457: 421-425.
16. Du GW, Yonekubo J, Zeng Y, Osisami M, Frohman MA. 2006. Design of expression vectors for RNA interference based on miRNAs and RNA splicing. FEBS J 273: 5421-5427.
17. Eulalio A, Huntzinger E, Izaurralde E. 2008. Getting to the root of miRNA-mediated gene silencing. Cell 132: 9-14.
18. Garzon R, Marcucci G, Croce CM. 2010. Targeting microRNAs in cancer: Rationale, strategies and challenges. Nat Rev Drug Discov 9: 775-789.
19. Ghivizzani SC, Gouze E, Gouze JN, Kay JD, Bush ML, Watson RS, Levings PP, Nickerson DM, Colahan PT, Robbins PD, Evans CH. 2008. Perspectives on the use of gene therapy for chronic joint diseases. Curr Gene Ther 8: 273-286.
20. Gottwein E, Cullen BR. 2008. Viral and cellular microRNAs as determinants of viral pathogenesis and immunity. Cell Host Microb 3: 375-387.
21. Grabherr R, Ernst W. 2010. Baculovirus for eukaryotic protein display. Curr Gene Ther 10: 195-200.
22. Grabundzija I, Irgang M, Mates L, Belay E, Matrai J, Gogol-Doring A, Kawakami K, Chen W, Ruiz P, Chuah MKL, VandenDriessche T, Izsvak Z, Ivics Z. 2010. Comparative analysis of transposable element vector systems in human cells. Mol Ther 18: 1200-1209.
23. Hackett PB, Largaespada DA, Cooper LJN. 2010. A transposon and transposase system for human application. Mol Ther 18: 674-683.
24. Ho Y-C, Lee H-P, Hwang S-M, Lo W-H, Chen H-C, Chung C-K, Hu Y-C. 2006. Baculovirus transduction of human mesenchymal stem cell-derived progenitor cells: Variation of transgene expression with cellular differentiation states. Gene Ther 13: 1471-1479.
25. Hu Y-C, Yao K, Wu T-Y. 2008. Baculovirus as an expression and/or delivery vehicle for vaccine antigens. Expert Rev Vaccine 7: 363-371.
26. Huang K-S, Lo W-H, Chung Y-C, Lai Y-K, Chen C-Y, Chou S-T, Hu Y-C. 2007. Combination of baculovirus-mediated gene delivery and packed-bed reactor for scalable production of adeno-associated virus. Hum Gene Ther 18: 1161-1170.
27. Ivics Z, Katzer A, Stuwe EE, Fiedler D, Knespel S, Izsvak Z. 2007. Targeted Sleeping Beauty transposition in human cells. Mol Ther 15: 1137-1144.
28. Izsvak Z, Hackett PB, Cooper LJN, Ivics Z. 2010. Translating Sleeping Beauty transposition into cellular therapies: Victories and challenges. Bioessays 32: 756-767.
29. Kelly EJ, Russell SJ. 2008. MicroRNAs and the regulation of vector tropism. Mol Ther 17: 409-416.
30. Khoury M, Courties G, Fabre S, Bouffi C, Seemayer CA, Vervoordeldonk MJ, Tak PP, Jorgensen C, Apparailly F. 2010. Adeno-associated virus type 5-mediated intraarticular administration of tumor necrosis factor small interfering RNA improves collagen-induced arthritis. Arthritis Rheum 62: 765-770.
31. Kost TA, Condreay JP, Ames RS. 2010. Baculovirus gene delivery: A flexible assay development tool. Curr Gene Ther 10: 168-173.
32. Kost TA, Condreay JP, Jarvis DL. 2005. Baculovirus as versatile vectors for protein expression in insect and mammalian cells. Nat Biotechnol 23: 567-575.
33. Lee H-P, Matsuura Y, Chen H-C, Chen Y-L, Chuang C-K, Abe T, Hwang S-M, Shiah H-C, Hu Y-C. 2009. Baculovirus transduction of chondrocytes elicits interferon-α/β and suppresses transgene expression. J Gene Med 11: 302-312.
34. Lesch HP, Laitinen A, Peixoto C, Vicente T, Makkonen KE, Laitinen L, Pikkarainen JT, Samaranayake H, Alves PM, Carrondo MJT, Yla-Herttuala S, Airenne KJ. 2011. Production and purification of lentiviral vectors generated in 293T suspension cells with baculoviral vectors. Gene Ther Epub online. DOI: 10.1038/gt.2010.1162.
35. Lesch HP, Turpeinen S, Niskanen EA, Mähönen AJ, Airenne KJ, Ylä-Herttuala S. 2008. Generation of lentivirus vectors using recombinant baculoviruses. Gene Ther 15: 1280-1286.
36. Lin C-Y, Lu C-H, Luo W-Y, Chang Y-H, Sung L-Y, Chiu H-Y, Hu Y-C. 2010. Baculovirus as a gene delivery vector for cartilage and bone tissue engineering. Curr Gene Ther 10: 242-254.
37. Liu CY-Y, Chen H-Z, Chao Y-C. 2010. Maximizing baculovirus-mediated foreign proteins expression in mammalian cells. Curr Gene Ther 10: 232-241.
38. Lo W-H, Hwang S-M, Chuang C-K, Chen C-Y, Hu Y-C. 2009. Development of a hybrid baculoviral vector for sustained transgene expression. Mol Ther 17: 658-666.
39. Madhan S, Prabakaran M, Kwang J. 2010. Baculovirus as vaccine vectors. Curr Gene Ther 10: 201-213.
40. Mates L, Chuah MKL, Belay E, Jerchow B, Manoj N, Acosta-Sanchez A, Grzela DP, Schmitt A, Becker K, Matrai J, Ma L, Samara-Kuko E, Gysemans C, Pryputniewicz D, Miskey C, Fletcher B, VandenDriessche T, Ivics Z, Izsvak Z. 2009. Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates. Nat Genet 41: 753-761.
41. Merrihew RV, Clay WC, Condreay JP, Witherspoon SM, Dallas WS, Kost TA. 2001. Chromosomal integration of transduced recombinant baculovirus DNA in mammalian cells. J Virol 75: 903-909.
42. O'Reilly D, Miller L, Luckow V. 1992. Baculovirus expression vectors: A laboratory manual. New York: W.H. Freeman and Co.
43. Ong ST, Li F, Du J, Tan YW, Wang S. 2005. Hybrid cytomegalovirus enhancer-H1 promoter-based plasmid and baculovirus vectors mediate effective RNA interference. Hum Gene Ther 16: 1404-1412.
44. Qiao C, Yuan Z, Li J, He B, Zheng H, Mayer C, Xiao X. 2010. Liver-specific microRNA-122 target sequences incorporated in AAV vectors efficiently inhibits transgene expression in the liver. Gene Ther 18: 403-410.
45. Sibley CR, Seow Y, Wood MJA. 2010. Novel RNA-based strategies for therapeutic gene silencing. Mol Ther 18: 466-476.
46. Staunstrup NH, Moldt B, Mates L, Villesen P, Jakobsen M, Ivics Z, Izsvak Z, Mikkelsen JG. 2009. Hybrid lentivirus-transposon vectors with a random integration profile in human cells. Mol Ther 17: 1205-1214.
47. Stegmeier F, Hu G, Rickles RJ, Hannon GJ, Elledge SJ. 2005. A lentiviral microRNA-based system for single-copy polymeraase II-regulated RNA interference in mammalian cells. Proc Natl Acad Sci USA 102: 13212-13217.
48. Strauss R, Huser A, Ni S, Tuve S, Kiviat N, Sow PS, Hofmann C, Lieber A. 2007. Baculovirus-based vaccination vectors allow for efficient induction of immune responses against Plasmodium falciparum circumsporozoite protein. Mol Ther 15: 193-202.
49. Suzuki H, Tamai N, Habu Y, Chang MOO, Takaku H. 2009. Suppression of hepatitis C virus replication by baculovirus vector-mediated short-hairpin RNA expression. FEBS Lett 582: 3085-3089.
50. Suzuki T, Chang MOO, Kitajima M, Takaku H. 2010. Induction of antitumor immunity against mouse carcinoma by baculovirus-infected dendritic cells. Cell Mol Immunol 7: 440-446.
51. Wang S, Balasundaram G. 2010. Potential cancer gene therapy by baculoviral transduction. Curr Gene Ther 10: 214-225.
52. Xue X, Huang X, Nodland SE, Mates L, Ma L, Izsvak Z, Ivics Z, LeBien TW, McIvor RS, Wagner JE, Zhou X. 2009. Stable gene transfer and expression in cord blood-derived CD34+ hematopoietic stem and progenitor cells by a hyperactive Sleeping Beauty transposon system. Blood 114: 1319-1330.
53. Zeng Y, Wagner EJ, Cullen BR. 2002. Both natural and designed micro RNAs can inhibit the expression of cognate mRNAs when expressed in human cells. Mol Cell 9: 1327-1333.